Harvoni 33.75 mg/150 mg and 45 mg/200 mg coated granules in sachet
*Company:
Gilead Sciences LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company

What is a Patient Information Leaflet and why is it useful?
A Patient Information Leaflet (PIL) is the leaflet for patients containing information on taking a medicine, that is included with the medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean that the version on medicines.ie may differ from the version found with your medicine. You can compare the “Leaflet prepared or revised date” towards the end of the leaflet in the pack with the version that is on the website to find out if there have been any changes to the information since your medicine was packed.
Gilead Sciences Ltd

Address:
280 High Holborn, London, WC1V 7EE, UKMedical Information E-mail:
ukmed.info@gilead.comTelephone:
+44 (0)203 681 4500Medical Information Direct Line:
+353 214 825 999 , 08000 113 700 (UK)Customer Care direct line:
+44 (0)203 681 4681